Our previous data indicated that GSCs with higher V-ATPase activity were more tumorigenic in vivo and in vitro, and that glioma patients with overexpression of the V-ATPase subunit G1 had a poorer prognosis irrespective of their grade and molecular characteristics [25]. Here, ATP6V1G1 is linked to glioma.